Pay in 4 interest-free payments of $6.60 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
This is a once-weekly subcutaneous injection that affects GIP (glucose-dependent insulinotrophic polypeptide) receptor and GLP-1 (glucagon-like peptide-1) receptor agonist, both appetite hormones
1995 Jun;8(6):565-71
These findings are consistent with prior studies that have documented the metabolic and cardiovascular benefits of arGLP-1, including reductions in glycated hemoglobin levels and blood pressure
For women dealing with PCOS-related insulin resistance, Oana Health also offers combination treatments that target hormonal balance and metabolic health
Due to this increase in off label use, patients should be aware and educated on treatment options, the impacts of off-label prescribing, and the side effects of these medications
US$ 20.28
US$ 27.35
US$ 20.73
US$ 23.37
US$ 26.65
US$ 22.94
